Autonomix Medical (AMIX) Liabilities and Shareholders Equity (2023 - 2025)

Autonomix Medical (AMIX) has 3 years of Liabilities and Shareholders Equity data on file, last reported at $10.2 million in Q4 2025.

• On a quarterly basis, Liabilities and Shareholders Equity fell 14.57% year-over-year to $10.2 million in Q4 2025; TTM through Dec 2025 was $36.9 million, a 9.23% increase from a year earlier, with the FY2025 full-year figure at $9.8 million, up 4.24% from the prior year.
• Liabilities and Shareholders Equity for Q4 2025 stood at $10.2 million, up from $7.9 million in the prior quarter.
• Over the last five years, Liabilities and Shareholders Equity for AMIX reached as high as $12.0 million in Q4 2024 and fell as low as $865000.0 in Q1 2023.
• Historically, Liabilities and Shareholders Equity has averaged $7.3 million across 3 years, with a median of $8.5 million in 2025.
• Across the five-year window, Liabilities and Shareholders Equity jumped 987.51% in 2024 and declined 14.57% in 2025, its largest moves.
• Year by year, Liabilities and Shareholders Equity stood at $1.8 million in 2023, then jumped by 560.7% to $12.0 million in 2024, then declined by 14.57% to $10.2 million in 2025.
• Per Business Quant data, the three most recent Liabilities and Shareholders Equity figures were $10.2 million in Q4 2025, $7.9 million in Q3 2025, and $9.0 million in Q2 2025.